Freestone Capital Holdings, LLC Taro Pharmaceutical Industries LTD Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$70.48 - $79.95 $115,093 - $130,558	-1,633 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$54.4 - $73.42 $33,619 - $45,373	-618 Reduced 27.45%	1,633 $120 Million
Q3 2020 Nov 06, 2020	BUY	$54.41 - $68.2 $122,476 - $153,518	2,251 New	2,251 $0
Q2 2020 Aug 04, 2020	SELL	$61.66 - $70.16 $242,385 - $275,798	-3,931 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$59.35 - $88.73 $616,290 - $921,372	-10,384 Reduced 72.54%	3,931 $241,000
Q4 2019 Feb 04, 2020	SELL	$74.18 - $97.92 $412,144 - $544,043	-5,556 Reduced 27.96%	14,315 $1.26 Million
Q3 2019 Nov 07, 2019	SELL	$75.36 - $86.57 $395,640 - $454,492	-5,250 Reduced 20.9%	19,871 $1.5 Million
Q2 2019 Aug 05, 2019	SELL	$83.92 - $108.88 $8.78 Million - $11.4 Million	-104,636 Reduced 80.64%	25,121 $2.15 Million
Q1 2019 May 08, 2019	BUY	$85.97 - $108.09 $2.85 Million - $3.58 Million	33,130 Added 34.29%	129,757 $14 Million
Q4 2018 Feb 12, 2019	SELL	$78.25 - $107.92 $3.45 Million - $4.76 Million	-44,092 Reduced 31.33%	96,627 $8.18 Million
Q3 2018 Nov 13, 2018	SELL	$97.82 - $116.09 $415,148 - $492,685	-4,244 Reduced 2.93%	140,719 $13.8 Million
Q2 2018 Aug 14, 2018	SELL	$97.62 - $120.59 $2.13 Million - $2.63 Million	-21,785 Reduced 13.06%	144,963 $16.8 Million
Q1 2018 May 15, 2018	BUY	$95.91 - $107.26 $2.05 Million - $2.29 Million	21,392 Added 14.72%	166,748 $16.5 Million
Q4 2017 Feb 13, 2018	SELL	$104.5 - $126.38 $222,062 - $268,557	-2,125 Reduced 1.44%	145,356 $15.2 Million
Q3 2017 Nov 14, 2017	BUY	$97.26 - $116.2 $460,137 - $549,742	4,731 Added 3.31%	147,481 $16.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	142,750	142,750 $16 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account